S. 164 · 117th Congress

Advancing Education on Biosimilars Act of 2021

Stage
Signed by the president
Sponsor
Maggie Hassan
Introduced
2021-02-02
Latest action
2021-04-23 · Signed by President.

Action history

  1. 2021-04-23Signed by President.
  2. 2021-04-23Became Public Law No: 117-8.
  3. 2021-04-20Presented to President.
  4. 2021-04-14Motion to reconsider laid on the table Agreed to without objection.
  5. 2021-04-14On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101).
  6. 2021-04-14Considered as unfinished business.
  7. 2021-04-14At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
  8. 2021-04-14DEBATE - The House proceeded with forty minutes of debate on S. 164.
  9. 2021-04-14Considered under suspension of the rules.
  10. 2021-04-14Mr. Pallone moved to suspend the rules and pass the bill.
  11. 2021-03-08Held at the desk.
  12. 2021-03-08Received in the House.
  13. 2021-03-08Message on Senate action sent to the House.
  14. 2021-03-03Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
  15. 2021-03-03Passed Senate without amendment by Unanimous Consent.
  16. 2021-02-02Introduced in Senate
  17. 2021-02-02Read twice and referred to the Committee on Health, Education, Labor, and Pensions.